We then focused on the germline mutations in cancer-related functional genes (Supplementary Table S5) and found a novel deleterious heterozygous nonsynonymous mutation (chr22:29091846, G->A, p.H371Y) in CHEK2, which is not recorded in the 1000 genome database and dbSNP137. This evidence concerns the gene CHEK2 and cancer.